News & Updates

Serum CTRP4 tied to coronary artery disease in T2DM
Serum CTRP4 tied to coronary artery disease in T2DM
17 Jul 2022

In patients with type 2 diabetes mellitus (T2DM), higher serum levels of circulating C1q tumour necrosis factor-related protein 4 (CTRP4) appear to aggravate the likelihood of coronary artery disease, a recent study has found.

Serum CTRP4 tied to coronary artery disease in T2DM
17 Jul 2022
Cardiovascular health metrics predict diabetes progression in prediabetic young adults
Cardiovascular health metrics predict diabetes progression in prediabetic young adults
10 Jul 2022

Cardiovascular health (CVH) metrics may help in stratifying the risk of diabetes in young adults with prediabetes, suggests a recent study. Thus, improving CVH metrics may result in a reduced risk of developing diabetes.

Cardiovascular health metrics predict diabetes progression in prediabetic young adults
10 Jul 2022
CVD prevention better with ACE inhibitor–statin combo than monotherapy
CVD prevention better with ACE inhibitor–statin combo than monotherapy
08 Jul 2022

In patients with hypertension, combined treatment with angiotensin-converting enzyme (ACE) inhibitors plus statins reduces the risk of developing cardiovascular disease (CVD) at a greater magnitude as compared with ACE inhibitor monotherapy, a study has found.

CVD prevention better with ACE inhibitor–statin combo than monotherapy
08 Jul 2022